Skip to ContentGo to accessibility pageKeyboard shortcuts menu
OpenStax Logo

Case Study

1.
c. The PTT is 75 seconds. Per the protocol, any PTT between 71 and 90 seconds will require a decrease in the heparin rate by 2 units/kg/hour.
2.
b. One of the advantages of LMWH is the longer duration of action, which means that once-daily injections, instead of continuous infusion, are effective.

Review Questions

1.
a. Heparin can be monitored by using the partial thromboplastin time or anti-factor Xa level, depending on the institutional protocol.
2.
a. Protamine is a protein that works to neutralize heparin.
3.
c. The antibodies decrease the platelet count, leaving the client at risk for the development of thrombosis.
4.
b. Alteplase is a thrombolytic drug used to dissolve clots.
5.
d. Heparin is an anticoagulant. It will prevent further clot formation while the body naturally breaks down the clot, but it will not directly dissolve the clot.
6.
d. Clients taking warfarin must maintain a consistent amount of vitamin K in their diet.
7.
b. Warfarin is monitored using the INR, or international normalized ratio.
8.
b. Heparin-induced thrombocytopenia is characterized by a decreased platelet count. Contrary to typical thrombocytopenia, the client is extremely hypercoagulable and often has a thrombosis such as a deep vein thrombosis.
9.
c. This drug is more effectively absorbed when taken with food.
10.
b. Severe uncontrolled hypertension is a contraindication to alteplase administration.
Citation/Attribution

This book may not be used in the training of large language models or otherwise be ingested into large language models or generative AI offerings without OpenStax's permission.

Want to cite, share, or modify this book? This book uses the Creative Commons Attribution License and you must attribute OpenStax.

Attribution information
  • If you are redistributing all or part of this book in a print format, then you must include on every physical page the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
  • If you are redistributing all or part of this book in a digital format, then you must include on every digital page view the following attribution:
    Access for free at https://openstax.org/books/pharmacology/pages/1-introduction
Citation information

© May 15, 2024 OpenStax. Textbook content produced by OpenStax is licensed under a Creative Commons Attribution License . The OpenStax name, OpenStax logo, OpenStax book covers, OpenStax CNX name, and OpenStax CNX logo are not subject to the Creative Commons license and may not be reproduced without the prior and express written consent of Rice University.